Finland· FI-REL-REL62010
Bimzelx
A bimekizumab product containing bimekizumab, registered in Finland by UCB Pharma SA. The same ATC class is registered in 14 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Bimekizumab is registered in 14 of 19 countries.
Countries holding a registration under ATC L04AC21 (bimekizumab), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 9 of them publish a price we can compare per daily dose
Bimekizumab · ATC L04AC21
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of bimekizumab costs, country by country.
Normalised to the WHO defined daily dose (5.7 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Bimekizumab · price per daily dose (5.7 mg)
USD · FX 28 Sept 2026
- CH Switzerland$43.14
The record
At a glance
Fimea (Finland)- Active substance
- Bimekizumab
- Manufacturer
- UCB Pharma SA
- Country
- Finland (FI)
- ATC code
- L04AC21
- ATC class
- Bimekizumab
- Defined daily dose
- 5.7 mg, P
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Bimekizumab in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaBIMZELXUCB Pharma SA, Brusel
- SwitzerlandBimzelx
- United StatesBimzelxUCB, Inc.
- CanadaBIMZELXUCB CANADA INC
- NetherlandsBimzelx 160 mg/ml, oplossing voor injectie in een voorgevulde penUCB Pharma S.A.
- PolandBimzelxUCB Pharma S.A.
- SwedenBimzelx 160 mg Injektionsvätska, lösning i förfylld injektionspennaUCB Pharma S.A.
- BelgiumBimzelx 160 mgUCB Pharma
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Bimzelx
- Liechtenstein · Bimzelx
- Norway · Bimzelx
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3843877b-eab5-4ab4-914c-c2eb0a9d1d67 GET /v1/drugs/3843877b-eab5-4ab4-914c-c2eb0a9d1d67?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "5.7",
"form": "injektioneste, liuos, esitäytetty kynä",
"route": "Ihon alle",
"ddd_unit": "mg",
"strength": "320 mg",
"atc_label": "bimekitsumabi",
"ma_number": null,
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": "EU/1/21/1575/011-012",
"fimea_rel_id": "REL62010",
"authorised_at": "2024-08-01"
}See everything about bimekizumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.